• Folder
  • Folder
Add items to your folder and easily email and print in bundles. View Folder
  • Search
    Close
Close
Close
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pharmaceutical and Medical Device

  • Add To Folder Remove From Folder
  • Print
  • Email

Related Services

  • National Trial Team & Leadership Team, AstraZeneca Seroquel Litigation: Alston & Bird is a member of AstraZeneca’s national trial team in the Seroquel litigation, the largest mass tort pharmaceutical litigation pending in 2010. Alston & Bird, in conjunction with AstraZeneca's other national counsel, has had unprecedented success in this litigation by excluding the testimony of the plaintiffs' specific causation experts in the vast majority of bellwether cases to date, including two cases in the Multi-District Litigation pending in Florida, three cases in consolidated litigation in Delaware state court, and one case in consolidated litigation in New Jersey state court. An article in The AmLaw Litigation Daily emphasized the success AstraZeneca has had with its defense strategy: “A pattern is forming in the ongoing product liability litigation over AstraZeneca's antipsychotic Seroquel, and it's not pretty for the plaintiffs.” While other companies manufacturing drugs of the same class have paid over a billion dollars in settlement, plaintiffs in Seroquel litigation have yet to obtain a favorable verdict.
  • Fresenius Medical Care, N.A., Regional Counsel, Dialysis Products Liability and Medical Negligence: Our team represents Fresenius Medical Care, N.A., the world's largest integrated provider of dialysis products and services, in products liability and complex medical negligence actions in various states throughout the country. In addition, we routinely render advice regarding state and federal compliance issues and regulatory requirements applicable to the client's network of end-stage renal disease facilities.
  • Clinical Trials Litigation: In 2009, we represented a global pharmaceutical company in a clinical trial wrongful death case filed in the Northern District of Florida. After developing a strong scientific evidence defense and prior to formal discovery, we settled the claim on behalf of the company at favorable terms. We have also represented and advised clients such as Amgen, Genentech and others in connection with clinical trials and biomedical research litigation in the United States and Canada. Our lawyers have written and lectured extensively on risk reduction and litigation avoidance strategies, including the litigation chapter of Barnett International’s 2003, 2004, 2005 and 2006 editions of Good Clinical Practice: A Question & Answer Guide.
  • National Trial Team, Bayer Corporation: Alston & Bird serves on the national trial team for both the Trasylol and YAZ/Yasmin pharmaceutical litigations. In addition, we serve as Bayer's Georgia counsel for the MDL and represent our client in individual state court cases in Connecticut and Pennsylvania. We have obtained key dismissals in many of these matters well in advance of trial, which has saved a significant amount in defense costs. We are also on the national trial team and are Georgia counsel in the YAZ/Yasmin pharmaceutical litigation. Previously, we have also represented Bayer in PPA litigation.
  • National Trial Team and National Science Counsel, GlaxoSmithKline, Phentermine (Fen-Phen) Litigation: As national science counsel for a major phentermine manufacturer in the diet drug litigation, Alston & Bird prepared the MDL Daubert brief and conducted the MDL Daubert hearing on behalf of all phentermine defendants. This hearing resulted in the exclusion of expert witnesses for plaintiff against the phentermine defendants. In the only “Fen-Phen” case tried against a phentermine defendant, we obtained a directed verdict in a Fayette, Mississippi state court case based on scientific evidence issues.
  • National Trial Team and National Science Counsel, 3M, Silicone Breast Implant Litigation: In litigation involving silicone breast implants, Alston & Bird lawyers were involved in the ground-breaking scientific evidence strategies that brought that mass tort to an end. We served as both national science counsel and as a member of the national trial team in breast implant litigation for 3M Corporation, one of the three major manufacturers in that litigation. Our partner Jane Thorpe was integral to the creation of the 706 National Science Panel appointed by the MDL judge, including helping to establish the Panel’s procedures and guidelines, and she coordinated and participated in virtually every Daubert hearing conducted by state and federal courts in those cases. On behalf of the joint defense, Jane presented much of the scientific evidence, by cross-examination of the plaintiffs’ experts and direct of the defense experts, considered by the 706 National Science Panel.
  • National Coordinating Counsel and National Trial Team, Natural Rubber Latex Glove Allergenicity Litigation: We served as national counsel for this mass tort litigation alleging severe allergic reactions to natural rubber latex. Our clients were the target defendants in litigation that threatened the very existence of the industry that provides 20 billion protective gloves to the medical profession annually. We litigated over 900 cases in federal and state courts nationwide. We obtained complete defense victories for our clients in five of six cases. The remaining case, tried in Beaumont, Texas, resulted in a verdict that was remitted and settled for a modest amount. We also coordinated the successful regulatory response to efforts to ban certain types of latex gloves in the European Union, and coordinated the ultimate settlement strategy nationally.
  • National Coordinating Counsel, Boehringer Ingelheim, Methadone and Pamidronate Litigation: We served as national coordinating counsel for Boehringer Ingelheim in pharmaceutical litigation pending in multiple jurisdictions regarding the drug methadone. We obtained summary judgment in a methadone wrongful death case and obtained a dismissal, with prejudice, in another wrongful death case. We also served as Boehringer’s national coordinating counsel in litigation pending in multiple jurisdictions, including an MDL in the Eastern District of New York and consolidated litigation in state court in New Jersey, against claims alleging pamidronate, a generic form of Aredia®, caused osteonecrosis of the jaw.